Melissa Block speaks with Facebook founder Mark Zuckerberg and Apple chairman Art Levinson about the multimillion-dollar prize they've created with other Silicon Valley illuminati to award advancements in research aimed at curing intractable diseases and extending human life. Eleven scientists have been named winners of the Breakthrough Prize this year.
Copyright ? 2013 NPR. For personal, noncommercial use only. See Terms of Use. For other uses, prior permission required.
MELISSA BLOCK, HOST:
If you win a Nobel Prize, you take home just over a million dollars. Well, today it was announced that 11 scientists have each won nearly triple that, $3 million. They're the first winners of a new prize created by a who's who of Silicon Valley billionaires. The Breakthrough Prize in life sciences was created to reward excellence in research to cure diseases and extend life.
The founding sponsors include Google co-founder Sergey Brin, Facebook founder Mark Zuckerberg and venture capitalist Yuri Milner. Milner has said he was motivated by illness within his own family and encouraged the others to contribute. The scientists who won say it came as a real surprise.
NAPOLEONE FERRARA: I was stunned. It was almost disbelief. First of all, I think I didn't know that this prize existed.
BLOCK: That's UC San Diego cancer researcher Napoleone Ferrara. Corey Bargmann(ph) of Rockefeller University, who studies the genetics of neural circuits, thought at first it was a practical joke or a version of the Nigerian scam. When she realized the $3 million prize money was real, she was elated.
CORNELIA BARGMANN: As a scientist, the work itself is so inspiring. But it's hard at times and sometimes you feel like people don't understand what you're doing or is it really worthwhile. And to have people like this get involved is a real vote of confidence. It's very encouraging to a scientist to feel that these people would take a step out from their very successful lives and appreciate what's going on in biology.
BLOCK: We're joined now by two of the Breakthrough Prize's founding sponsors, Art Levinson, who's chairman of Genentech and Apple, and Mark Zuckerberg, the founder of Facebook. Welcome to both of you.
ART LEVINSON: Thanks for having us.
MARK ZUCKERBERG: Thank you very much.
BLOCK: And Mark what would you say is the guiding principal behind these awards? What are you rewarding?
ZUCKERBERG: The main thing that I'm really excited about here is that I think that our society needs more heroes who are scientists and researchers and engineers. And, you know, the people who are getting this award are doing the real work. But the thing that we can do from the sidelines is set up these these institutions that can celebrate their work and reward them. And I'm really honored to be a part of this institution that is setup to reward these folks for the great work that they're doing.
BLOCK: It seems that personal experience among the founding sponsors, specifically family members who had the disease - who have suffered from disease - was motivating some of the prize money here.
ZUCKERBERG: I think so. But for me, this prize is really about the next generation, right? It's about the students who are in college and grad school or in the labs, and are trying to figure out what they want to research and work on next. It's about kids who are growing up and want to figure out what they want to be when they grow up and look to signals like this for inspiration.
And if we can play a role in helping more people to really important work that improve a lot of people's lives, then I think that that's an awesome thing for us to spend our time doing.
BLOCK: And, Art, let's talk about the winners here, that it's heavy on your list of - the winners are heavy in the Human Genome Project and cancer research. And these are big prominent names, many of them connected with very well-funded institutions; Johns Hopkins and MIT. We're not talking about underdogs here who are scrapping and really needing funding, right?
LEVINSON: They're not certainly underdogs. And as a result of their really fantastic efforts, for the most part, everybody is really quite well-funded, although, as we face the prospect of sequester and, you know, potential reductions to the NIH budget - which, after all, fund so much of the basic research at least in this country - we're looking at potentially pretty tight times ahead.
BLOCK: Why do you think that this field, and specifically cancer research and gene research, why is this where the money can do the most good and with these winners?
LEVINSON: Well, the way we approach the selection winners was to take a look at those scientists who have made the fundamental discoveries really independent of any particular therapeutic discipline. But then, layered on top of that, we wanted to also address people who are tackling some of the most intractable diseases, like cancer, like immunological disorders, neurological disorders.
So we put a certain emphasis on those individuals who had a translational component to their work, affecting people who have some of the most serious diseases known.
BLOCK: I wonder if there would be scientists listening to this who are working really hard at unheralded, not very well-funded institutions, who would look at this list of names and say, these guys don't need $3 million.
(LAUGHTER)
BLOCK: They're doing fine. I need $3 million.
LEVINSON: Well, they might be wondering that. But, at the same time, one has to, you know, apportion any kind of prizes among those who have really made the most important achievements. So I don't really know any other way to do it than to really shine the spotlight on the people who have made kind of contributions. And hopefully they'll serve as wonderful role models to the younger generation.
BLOCK: Does the Breakthrough Prize set out any priorities for how the money should be spent?
LEVINSON: Oh no, it's a personal contribution to the person, to the individual who has received the award.
BLOCK: Which means they could do with it what they want.
LEVINSON: They can do - they can go on a cruise or they can continue and expand their own research efforts, if they so choose. It's completely flexible.
BLOCK: What's your hope, Mr. Levinson, for what comes from this prize money?
LEVINSON: My fondest hope is that it would be widespread recognition of the winners who have worked so hard over the course of so many years to make these fundamental discoveries. And beyond that, to make sure it to some extent that this process is revealed to some of the young people making career choices. Science is a fantastic field. Few of us went to the field initially with the idea that we were going to go into the field to make a lot of money.
It was driven by a fundamental interest in basic discovery; that's certainly my own background here. And this just maybe provides an opportunity to show that if one is successful, you know, in addition to all the joys associated with basic discovery, that there's a possibility for additional forms of recognition.
BLOCK: Art Levinson and Mark Zuckerberg, thanks so much for talking with us.
LEVINSON: Pleasure being here, thank you.
ZUCKERBERG: Thanks for having us. We're really excited about this.
BLOCK: That's Facebook founder Mark Zuckerberg and chairman of Apple and Genentech, Art Levinson. They're founding sponsors of the Breakthrough Prizes in life sciences, which were awarded to 11 researchers today
Copyright ? 2013 NPR. All rights reserved. No quotes from the materials contained herein may be used in any media without attribution to NPR. This transcript is provided for personal, noncommercial use only, pursuant to our Terms of Use. Any other use requires NPR's prior permission. Visit our permissions page for further information.
NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.
Kirk Urso London 2012 Javelin roger federer Olga Korbut Usain Bolt 2012 Olympics Katie Ledecky Aaron Ross
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন